title: Delayed onset of pseudomembranous colitis after rifampin therapy.
abstract: Rifampin therapy is an infrequently reported cause of pseudomembranous colitis. A low index of suspicion may account for this lack of recognition. Awareness of this potentially hazardous complication of rifampin therapy is encouraged, especially since increasing numbers of patients infected with the human immunodeficiency virus, who may have diarrhea from other etiologies, require rifampin therapy.
authors.affiliation: Division of Pulmonary Medicine, Veterans Affairs Medical Center, Mountain Home, Tenn 87684-4000, USA.
authors.forename: R P
authors.initials: RP
authors.lastname: Byrd
authors.forename: T M
authors.initials: TM
authors.lastname: Roy
authors.forename: M A
authors.initials: MA
authors.lastname: Ossorio
authors.forename: C L
authors.initials: CL
authors.lastname: Fields
mesh_terms: D000904:Antibiotics, Antitubercular / Q000009:adverse effects*; D000930:Antidiarrheals / Q000627:therapeutic use; D016360:Clostridioides difficile / Q000302:isolation & purification; D003937:Diagnosis, Differential; D003967:Diarrhea / Q000139:chemically induced / Q000188:drug therapy / Q000382:microbiology; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced* / Q000188:drug therapy / Q000382:microbiology; D019053:HIV Enteropathy / Q000175:diagnosis; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects*
chemical_list: D000904:Antibiotics, Antitubercular; D000930:Antidiarrheals; D008795:Metronidazole; D012293:Rifampin